Cargando…

Corrigendum: Combining different bacteria in vaccine formulations enhances the chance for antiviral cross-reactive immunity: a detailed in silico analysis for influenza A virus

Detalles Bibliográficos
Autores principales: Bodas-Pinedo, Andrés, Lafuente, Esther M., Pelaez-Prestel, Hector F., Ras-Carmona, Alvaro, Subiza, Jose L., Reche, Pedro A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516439/
https://www.ncbi.nlm.nih.gov/pubmed/37744348
http://dx.doi.org/10.3389/fimmu.2023.1284628
_version_ 1785109128566276096
author Bodas-Pinedo, Andrés
Lafuente, Esther M.
Pelaez-Prestel, Hector F.
Ras-Carmona, Alvaro
Subiza, Jose L.
Reche, Pedro A.
author_facet Bodas-Pinedo, Andrés
Lafuente, Esther M.
Pelaez-Prestel, Hector F.
Ras-Carmona, Alvaro
Subiza, Jose L.
Reche, Pedro A.
author_sort Bodas-Pinedo, Andrés
collection PubMed
description
format Online
Article
Text
id pubmed-10516439
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-105164392023-09-23 Corrigendum: Combining different bacteria in vaccine formulations enhances the chance for antiviral cross-reactive immunity: a detailed in silico analysis for influenza A virus Bodas-Pinedo, Andrés Lafuente, Esther M. Pelaez-Prestel, Hector F. Ras-Carmona, Alvaro Subiza, Jose L. Reche, Pedro A. Front Immunol Immunology Frontiers Media S.A. 2023-09-08 /pmc/articles/PMC10516439/ /pubmed/37744348 http://dx.doi.org/10.3389/fimmu.2023.1284628 Text en Copyright © 2023 Bodas-Pinedo, Lafuente, Pelaez-Prestel, Ras-Carmona, Subiza and Reche https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Bodas-Pinedo, Andrés
Lafuente, Esther M.
Pelaez-Prestel, Hector F.
Ras-Carmona, Alvaro
Subiza, Jose L.
Reche, Pedro A.
Corrigendum: Combining different bacteria in vaccine formulations enhances the chance for antiviral cross-reactive immunity: a detailed in silico analysis for influenza A virus
title Corrigendum: Combining different bacteria in vaccine formulations enhances the chance for antiviral cross-reactive immunity: a detailed in silico analysis for influenza A virus
title_full Corrigendum: Combining different bacteria in vaccine formulations enhances the chance for antiviral cross-reactive immunity: a detailed in silico analysis for influenza A virus
title_fullStr Corrigendum: Combining different bacteria in vaccine formulations enhances the chance for antiviral cross-reactive immunity: a detailed in silico analysis for influenza A virus
title_full_unstemmed Corrigendum: Combining different bacteria in vaccine formulations enhances the chance for antiviral cross-reactive immunity: a detailed in silico analysis for influenza A virus
title_short Corrigendum: Combining different bacteria in vaccine formulations enhances the chance for antiviral cross-reactive immunity: a detailed in silico analysis for influenza A virus
title_sort corrigendum: combining different bacteria in vaccine formulations enhances the chance for antiviral cross-reactive immunity: a detailed in silico analysis for influenza a virus
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516439/
https://www.ncbi.nlm.nih.gov/pubmed/37744348
http://dx.doi.org/10.3389/fimmu.2023.1284628
work_keys_str_mv AT bodaspinedoandres corrigendumcombiningdifferentbacteriainvaccineformulationsenhancesthechanceforantiviralcrossreactiveimmunityadetailedinsilicoanalysisforinfluenzaavirus
AT lafuenteestherm corrigendumcombiningdifferentbacteriainvaccineformulationsenhancesthechanceforantiviralcrossreactiveimmunityadetailedinsilicoanalysisforinfluenzaavirus
AT pelaezprestelhectorf corrigendumcombiningdifferentbacteriainvaccineformulationsenhancesthechanceforantiviralcrossreactiveimmunityadetailedinsilicoanalysisforinfluenzaavirus
AT rascarmonaalvaro corrigendumcombiningdifferentbacteriainvaccineformulationsenhancesthechanceforantiviralcrossreactiveimmunityadetailedinsilicoanalysisforinfluenzaavirus
AT subizajosel corrigendumcombiningdifferentbacteriainvaccineformulationsenhancesthechanceforantiviralcrossreactiveimmunityadetailedinsilicoanalysisforinfluenzaavirus
AT rechepedroa corrigendumcombiningdifferentbacteriainvaccineformulationsenhancesthechanceforantiviralcrossreactiveimmunityadetailedinsilicoanalysisforinfluenzaavirus